Janux Therapeutics

1 follower


Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.

Industries

Employees

51-200

Links

Org chart

David Campbell
President & CEO

David Campbell

Collapse
Tighe Reardon
Acting CFO
Andy Meyer
Chief Business Officer
Byron Robinson
Chief Strategy Officer
Carolina Caffaro
Vice President, CMC
Jerry Warren
Senior Director Regulatory Affairs
Sara Walsh
Executive Administrative Assistant to the President and Chief Executive Officer
James Pennington
General Counsel
Zachariah McIver
Chief Medical Officer
Tommy DiRaimondo
Executive Director, Research & Development

Board & advisors